FDA Issues 46 Fresh Product-Specific Guidances
The 25 New And 21 Revised PSGs Include Guidance On Ophthalmic And Inhaled Products
Executive Summary
The latest batch of product-specific guidance documents to aid generic development has been published by the US FDA, with the 46 new and revised PSGs covering products including an ophthalmic implant, nasal sprays and powders for inhalation.
You may also be interested in...
UAE’s Bioventure Is Looking For Partners To Expand
Having recently added to its biosimilars alliance with Alvotech, Dubai-based Bioventure says it is looking to expand its international reach through further partnerships.
Medicines For Europe Highlights Industry Agenda
Ahead of its annual meeting in Malta in mid-June, European off-patent industry association Medicines for Europe has set out the hot topics for generics and biosimilars stakeholders that delegates will be looking to discuss.
Who’s Hired? New Mithra CEO Mulls Selling Generics Business
Mithra’s new CEO has immediately signaled a potential sale for the firm’s generics business as it looks to focus on branded assets in women’s health. Meanwhile, Sawai has reorganized its management team, the longtime chair of Viatris is moving on to another role, and a former AAM vice-president has joined Sandoz.